Saw this today on fool. No surprise the broker is Morgans.Paradigm Biopharmaceuticals Ltd(ASX: PAR)
A note out ofMorgansreveals that its analysts have retained theirreducerating and $1.69 price target on this biopharmaceutical company’s shares. According to the note, the broker wasn’t surprised to see the US FDA put Paradigm’s investigational new drug (IND) application on hold. Morgans believes that a decision could be months away, which will lead to further cash burn and uncertainty. The broker has previously stated that it sees risk to the viability of the company’s osteoarthritis drug as a commercial asset. The Paradigm share price is fetching $2.33 today.
https://www.********.au/2021/05/04/leading-brokers-name-3-asx-shares-to-sell-today-4-may-2021/
Saw this today on fool. No surprise the broker is Morgans....
-
- There are more pages in this discussion • 2,866 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $78.70M | |||
| Open | High | Low | Value | Volume |
| 22.8¢ | 23.0¢ | 22.5¢ | $10.81K | 47.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5397 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 149266 | 10 |
View Market Depth
| Last trade - 12.31pm 16/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |